This review summarizes the pathogenesis, diagnostics, prognosis, and treatment opportunities for cardiorenal syndrome in chronic heart failure, with an emphasis on modern biomarker strategies.
May aid biomarker-informed cardiorenal syndrome management; leaves open prospective validation in chronic heart failure.
The review focuses on cardiorenal syndrome developing in patients with chronic heart failure. The specifics of pathogenesis is discussed, as diagnostics and prognosis, with emphasis on the opportunities of modern biomarker strategy. The complicated cardiorenal issues are discussed and perspectives of their further exploration for treatment tactics in cohort of heart failure patients.
No takes yet. Share an insight, caveat, or question.
Медведева et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: